US Stock MarketDetailed Quotes
CORT Corcept Therapeutics
- 22.950
- +0.290+1.28%
Close Apr 19 16:00 ET
- 22.950
- 0.0000.00%
Post 16:24 ET
2.38BMarket Cap24.41P/E (TTM)
23.030High22.560Low924.78KVolume22.600Open22.660Pre Close21.16MTurnover1.09%Turnover Ratio24.41P/E (Static)103.84MShares34.27552wk High4.70P/B1.95BFloat Cap20.86952wk Low--Dividend TTM85.09MShs Float34.275Historical High--Div YieldTTM2.07%Amplitude0.680Historical Low22.875Avg Price1Lot Size
Corcept Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.58%127.04M | -82.37%5.89M | 57.24%52.91M | 134.40%42.29M | -26.36%25.96M | -28.33%120.32M | -32.45%33.39M | -30.91%33.65M | -59.31%18.04M | 38.65%35.25M |
| Net income from continuing operations | 4.66%106.14M | 88.87%31.36M | -9.33%31.38M | 0.42%27.53M | -30.35%15.88M | -9.86%101.42M | -48.21%16.6M | 13.58%34.61M | 3.35%27.41M | -2.85%22.8M |
| Depreciation and amortization | -31.46%2.36M | -48.53%630K | -77.53%169K | 23.20%823K | -7.73%740K | -0.86%3.45M | 1.49%1.22M | -2.46%752K | -11.64%668K | 7.94%802K |
| Deferred tax | 13.01%-29.49M | 17.80%-3.67M | 0.18%-8.86M | 3.69%-10.24M | 32.30%-6.73M | -880.14%-33.91M | -294.30%-4.47M | -315.99%-8.87M | -422.22%-10.63M | -85.35%-9.94M |
| Other non cash items | ---- | ---- | -1,196.81%-2.75M | -319.50%-1.68M | -235.90%-1.5M | ---- | ---- | -81.18%251K | -40.17%764K | -7.37%1.11M |
| Change In working capital | 48.37%8.22M | -415.18%-32.3M | 651.48%20.1M | 229.80%13.99M | -33.86%6.43M | 1,288.63%5.54M | 478.60%10.25M | -441.20%-3.64M | -861.30%-10.78M | 305.80%9.72M |
| -Change in receivables | 42.26%-10.07M | 58.47%-6.5M | -65.84%-2.07M | 100.41%4K | -435.57%-1.5M | -1,121.58%-17.43M | -1,300.45%-15.64M | -212.41%-1.25M | 81.81%-986K | -88.82%447K |
| -Change in inventory | 5.50%1.27M | 163.20%329K | -229.83%-544K | 12.71%922K | 442.33%558K | -65.19%1.2M | -84.16%125K | -47.43%419K | -17.54%818K | -118.82%-163K |
| -Change in prepaid assets | -76.96%-11.6M | -209.92%-6.38M | 24.94%-6.43M | 109.59%363K | 9,522.22%848K | -63.68%-6.56M | 437.95%5.81M | -3,455.60%-8.57M | -571.36%-3.79M | 99.68%-9K |
| -Change in payables and accrued expense | -3.41%31.39M | -180.85%-18.19M | 362.81%29.22M | 311.60%13.28M | -28.89%7.09M | 1,892.83%32.5M | 578.88%22.5M | 5,317.36%6.31M | -233.82%-6.28M | 259.45%9.97M |
| -Change in other current assets | 24.91%-1.48M | ---- | ---- | ---- | ---- | -203.03%-1.98M | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | 41.38%-1.29M | 86.88%-74K | 87.07%-72K | -4.17%-575K | -7.98%-568K | -8.59%-2.2M | -8.46%-564K | -8.58%-557K | -8.66%-552K | -8.68%-526K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.58%127.04M | -82.37%5.89M | 57.24%52.91M | 134.40%42.29M | -26.36%25.96M | -28.33%120.32M | -32.45%33.39M | -30.91%33.65M | -59.31%18.04M | 38.65%35.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 179.51%90.91M | 199.17%17.1M | -2,187.47%-109.57M | 42.35%-24.1M | 510.87%207.48M | -183.99%-114.33M | -112.27%-17.24M | 81.44%-4.79M | -268.94%-41.8M | -1,437.64%-50.5M |
| Net PPE purchase and sale | 66.34%-139K | --0 | 89.46%-37K | -436.84%-102K | --0 | 11.94%-413K | 52.31%-31K | -120.75%-351K | 84.03%-19K | 90.48%-12K |
| Net investment purchase and sale | 179.92%91.05M | 199.35%17.1M | -2,367.52%-109.53M | 42.57%-24M | 510.97%207.48M | -183.40%-113.91M | -112.25%-17.21M | 82.69%-4.44M | -268.06%-41.78M | -1,498.61%-50.48M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 179.51%90.91M | 199.17%17.1M | -2,187.47%-109.57M | 42.35%-24.1M | 510.87%207.48M | -183.99%-114.33M | -112.27%-17.24M | 81.44%-4.79M | -268.94%-41.8M | -1,437.64%-50.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -760.47%-148.72M | 1,355.74%766K | 71.95%-3.92M | -5,188.61%-145.75M | 135.77%181K | 94.29%-17.28M | 99.97%-61K | 40.95%-13.96M | 89.41%-2.76M | 98.90%-506K |
| Net common stock issuance | ---145.43M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 32.64%5.81M | 124.33%1.76M | -38.83%4.2M | 66.54%-1.55M | 1.95%1.41M | -73.01%4.38M | -74.24%785K | 56.01%6.86M | -197.81%-4.64M | -65.78%1.38M |
| Net other financing activities | 57.97%-9.11M | -17.61%-995K | ---- | ---- | 34.96%-1.23M | 5.12%-21.67M | 66.38%-846K | ---- | ---- | 88.52%-1.89M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -760.47%-148.72M | 1,355.74%766K | 71.95%-3.92M | -5,188.61%-145.75M | 135.77%181K | 94.29%-17.28M | 99.97%-61K | 40.95%-13.96M | 89.41%-2.76M | 98.90%-506K |
| Net cash flow | ||||||||||
| Beginning cash position | -14.54%66.33M | 122.52%111.8M | 387.68%172.38M | 384.86%299.94M | -14.54%66.33M | 1.87%77.62M | -46.94%50.24M | -62.96%35.35M | 18.10%61.86M | 1.87%77.62M |
| Current changes in cash | 713.24%69.22M | 47.65%23.75M | -506.64%-60.58M | -381.09%-127.57M | 1,582.79%233.61M | -891.03%-11.29M | 194.23%16.09M | 2,107.68%14.9M | -161.59%-26.52M | 33.83%-15.76M |
| End cash Position | 104.36%135.55M | 104.36%135.55M | 122.52%111.8M | 387.68%172.38M | 384.86%299.94M | -14.54%66.33M | -14.54%66.33M | -46.94%50.24M | -62.96%35.35M | 18.10%61.86M |
| Free cash flow | 5.83%126.9M | -82.35%5.89M | 58.79%52.87M | 134.08%42.18M | -26.33%25.96M | -28.38%119.91M | -32.42%33.36M | -31.41%33.3M | -59.25%18.02M | 39.29%35.24M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg